Cargando…
Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease
Cannabidiol (CBD) is a non-psychoactive phytocannabinoid known for its beneficial effects including antioxidant and anti-inflammatory properties. Moreover, CBD is a compound with antidepressant, anxiolytic, anticonvulsant and antipsychotic effects. Thanks to all these properties, the interest of the...
Autores principales: | Silvestro, Serena, Schepici, Giovanni, Bramanti, Placido, Mazzon, Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664437/ https://www.ncbi.nlm.nih.gov/pubmed/33171772 http://dx.doi.org/10.3390/molecules25215186 |
Ejemplares similares
-
Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson’s Disease
por: Schepici, Giovanni, et al.
Publicado: (2020) -
Traumatic Brain Injury and Stem Cells: An Overview of Clinical Trials, the Current Treatments and Future Therapeutic Approaches
por: Schepici, Giovanni, et al.
Publicado: (2020) -
The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical
Trials
por: Schepici, Giovanni, et al.
Publicado: (2019) -
Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases
por: Schepici, Giovanni, et al.
Publicado: (2020) -
Autism Spectrum Disorder and miRNA: An Overview of Experimental Models
por: Schepici, Giovanni, et al.
Publicado: (2019)